'Bug bomb' foggers still making people sick

February 2, 2018 by Margaret Steele, Healthday Reporter

(HealthDay)—Improperly used "bug bombs" are making Americans sick—and improved labeling isn't helping, government health officials say.

Pesticide foggers are often used indoors to combat insects, such as fleas, cockroaches and bed bugs. But directions must be followed carefully because breathing the spray mist can cause respiratory and .

More than 3,200 bug bomb-related illnesses—including four deaths—were identified in 10 states between 2007 and 2015, according to the new report.

Failure to leave the home during the "bombing" and early re-entry were the most common reasons for pesticide exposure, the researchers said.

Excessive fogger use—another culprit—was tied to more severe respiratory or gastrointestinal symptoms.

To reduce the risk of illness, the U.S. Environmental Protection Agency required improved labels on these "total release foggers" made after September 2012.

But the investigators found no significant difference in the number of bug-bomb illnesses reported in the first three years after the new labeling took effect.

"Integrated pest management strategies need to be adopted, as well as better communication about the hazards and proper uses of [total release foggers]," Ruiling Liu and colleagues wrote in the report. Liu is with the U.S. Centers for Disease Control and Prevention's National Institute for Occupational Safety and Health.

More than nine in 10 fogger-related chemical exposures occurred in homes, with 5 percent of patients aged 5 years or younger. Another 14 percent were 60 or older, the report noted.

Although the updated labeling includes illustrations, researchers found the directions often went unread or ignored. For example, many users left the treated room but not the premises, as directed.

Or they left home, but returned to retrieve a pet or forgotten item.

However, some users ventilated treated homes the recommended length of time or longer, but still got sick. This might mean the recommended ventilation period is insufficient, the report suggested.

Patients' symptoms included cough, trouble breathing and upper respiratory pain or irritation. Vomiting, nausea, and abdominal pain or cramping were among other complaints, the findings showed.

Because pre-existing asthma was linked to more severe illness, the researchers said a special warning might be needed for people with this respiratory condition.

The chemicals most often involved were pyrethroid (78 percent of cases) and pyrethrin (24 percent), according to the report.

If you come into contact with the fogging chemicals, health experts say you should leave the area at once and wash your skin. But avoiding the pesticides from the get-go is even better, they advise.

"In order to avoid toxic exposures, do not use foggers in small, enclosed spaces, and inform your loved ones if an area has been treated," said Dr. Payal Sud, a medical toxicologist in New York who was not involved with the new .

"Especially keep your children and pets away from the treated area," added Sud, associate chair of Northwell Health's Glen Cove Hospital.

"When you return to the area, make sure the doors and windows are opened to promote ventilation of the fumes," Sud said.

The findings were published in the Feb. 2 issue of the CDC's Morbidity and Mortality Weekly Report.

Explore further: US flu season gets worse, has 'lot more steam' than expected

More information: Payal Sud, M.D., associate chair, Northwell Health Glen Cove Hospital, Glen Cove, N.Y.; Feb. 2, 2018, U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report

The U.S. Environmental Protection Agency outlines safety precautions for bug-bomb use.

Related Stories

US flu season gets worse, has 'lot more steam' than expected

January 20, 2018
The flu season in the U.S. is getting worse.

Illnesses caused by recreation on the water costs $2.9 billion annually in the US

January 9, 2018
Swimming, paddling, boating and fishing account for more than 90 million cases of gastrointestinal, respiratory, ear, eye and skin-related illnesses per year in the U.S. with an estimated annual cost of $2.9 billion, according ...

FDA bans use of opioid-containing cough meds by kids

January 12, 2018
(HealthDay)—Trying to put a dent in the ongoing opioid addiction crisis, the U.S. Food and Drug Administration on Thursday slapped strict new restrictions on the use of opioid-containing cold and cough products by kids.

Childbirth deaths declining in U.S., new report finds

January 4, 2018
(HealthDay)—Improved management of excessive bleeding and high blood pressure during labor and delivery are helping to reduce the number of childbirth-related deaths in the United States, maternal health experts say.

Chlorine + pee = breathing trouble for waterpark workers

September 21, 2017
(HealthDay)—Another summer ends, and at least some of America's waterpark attendants may be breathing easier, a new report finds.

Recommended for you

Antifungal agent found to be possible treatment for porphyria

September 24, 2018
A large team of researchers from Spain, France and the U.S. has found that a common antifungal agent might be useful as a treatment for a rare type of porphyria. In their paper published in the journal Science Translational ...

New findings on the muscle disease Laing early-onset distal myopathy

September 24, 2018
New avenues are now being opened toward treatment of Laing distal myopathy, a rare disorder that causes atrophy of the muscles in the feet, hands and elsewhere. In a study published in the journal PNAS, researchers have identified ...

Insulin shows great potential against chronic colitis

September 24, 2018
Diabetes is not the only disease on which insulin has an effect, it appears. In a new study using tests on mice, researchers from the University of Copenhagen, among others, have discovered a new method for treating chronic ...

A new approach to developing a vaccine against vivax malaria

September 21, 2018
A novel study reports an innovative approach for developing a vaccine against Plasmodium vivax, the most prevalent human malaria parasite outside sub-Saharan Africa. The study led by Hernando A. del Portillo and Carmen Fernandez-Becerra, ...

Pre-clinical success for a universal flu vaccine offers hope for third generation approach

September 21, 2018
Researchers from the University of Oxford's Department of Zoology have demonstrated pre-clinical success for a universal flu vaccine in a new paper published in Nature Communications.

Researchers define possible molecular pathway for neurodegeneration in prion diseases

September 21, 2018
A new study has shed light on the mechanisms underlying the progression of prion diseases and identified a potential target for treatment.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.